Tags: Physiology · Bone
Project: r01_doug_adams
471 significantly associated models · 69 unique genes
# | chr | p0 | p1 | # assoc genes | # joint models | best TWAS P | best SNP P | cond SNP P | % var exp | joint genes |
---|---|---|---|---|---|---|---|---|---|---|
1 | 10 | 87823507 | 96755402 | 67 | 7 | 8.9e-13 | 1.3e-11 | NaN | NaN | Cacng5 Wipi1 Map2k6 Marchf10 Strada Cep95 Prkar1a |
2 | 10 | 99794956 | 101075728 | 1 | 1 | 8.7e-08 | 2.1e-06 | 7.3e-47 | -818 | Cd300lf |
3 | 10 | 102999385 | 104282175 | 1 | 1 | 2.2e-07 | 2.5e-05 | 6.0e-02 | 80 | Cep295nl |
p0: physical position of the start of the locus. p1: physical position of the end of the locus. # joint models: number of models selected by step-wise conditional analysis.
chisq ratio: Average Chi2 statistic for the selected genes in the secondary trait, divided by the average statistic for all genes in the secondary trait. # genes+: Shared significant genes at Bonferroni correction. # genes++: Shared significant genes at transcriptome-wide significance. % genes++: Number of [++] genes as a percentage of primary trait’s total joint genes. corr: Correlation of effect sizes across the [+] genes.
tissue | modality | # hits | % hits/tests | avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 14 | 0.660 | 2.1 |
Adipose | alternative TSS | 0 | 0.000 | 1.8 |
Adipose | gene expression | 26 | 0.313 | 2.0 |
Adipose | isoform ratio | 7 | 0.248 | 2.0 |
Adipose | intron excision ratio | 6 | 0.206 | 2.2 |
Adipose | mRNA stability | 13 | 0.377 | 2.1 |
BLA | alternative polyA | 5 | 0.417 | 2.1 |
BLA | alternative TSS | 8 | 0.950 | 2.2 |
BLA | gene expression | 30 | 0.495 | 2.2 |
BLA | isoform ratio | 5 | 0.284 | 2.0 |
BLA | intron excision ratio | 5 | 0.167 | 2.0 |
BLA | mRNA stability | 8 | 0.395 | 2.1 |
Brain | alternative polyA | 8 | 0.399 | 2.0 |
Brain | alternative TSS | 15 | 0.874 | 2.2 |
Brain | gene expression | 29 | 0.320 | 2.0 |
Brain | isoform ratio | 12 | 0.380 | 2.1 |
Brain | intron excision ratio | 14 | 0.259 | 2.1 |
Brain | mRNA stability | 8 | 0.183 | 2.0 |
Eye | alternative polyA | 0 | 0.000 | 2.0 |
Eye | alternative TSS | 0 | 0.000 | 1.8 |
Eye | gene expression | 5 | 0.444 | 2.3 |
Eye | isoform ratio | 0 | 0.000 | 1.8 |
Eye | intron excision ratio | 3 | 0.489 | 2.0 |
Eye | mRNA stability | 0 | 0.000 | 2.0 |
IL | alternative polyA | 0 | 0.000 | 2.1 |
IL | alternative TSS | 1 | 0.346 | 2.0 |
IL | gene expression | 12 | 0.329 | 2.1 |
IL | isoform ratio | 1 | 0.127 | 2.1 |
IL | intron excision ratio | 1 | 0.104 | 2.0 |
IL | mRNA stability | 3 | 0.270 | 2.0 |
LHb | alternative polyA | 0 | 0.000 | 2.0 |
LHb | alternative TSS | 3 | 0.857 | 2.2 |
LHb | gene expression | 8 | 0.250 | 2.1 |
LHb | isoform ratio | 1 | 0.133 | 2.0 |
LHb | intron excision ratio | 1 | 0.097 | 2.0 |
LHb | mRNA stability | 7 | 0.676 | 2.1 |
Liver | alternative polyA | 5 | 0.333 | 1.9 |
Liver | alternative TSS | 11 | 0.724 | 2.0 |
Liver | gene expression | 21 | 0.292 | 2.0 |
Liver | isoform ratio | 6 | 0.251 | 1.9 |
Liver | intron excision ratio | 16 | 0.366 | 2.2 |
Liver | mRNA stability | 7 | 0.285 | 2.0 |
NAcc | alternative polyA | 6 | 0.458 | 2.1 |
NAcc | alternative TSS | 1 | 0.108 | 1.8 |
NAcc | gene expression | 28 | 0.444 | 2.1 |
NAcc | isoform ratio | 2 | 0.106 | 1.9 |
NAcc | intron excision ratio | 4 | 0.131 | 2.0 |
NAcc | mRNA stability | 13 | 0.575 | 2.1 |
OFC | alternative polyA | 2 | 0.342 | 2.1 |
OFC | alternative TSS | 0 | 0.000 | 1.7 |
OFC | gene expression | 13 | 0.351 | 2.2 |
OFC | isoform ratio | 2 | 0.245 | 2.0 |
OFC | intron excision ratio | 0 | 0.000 | 2.2 |
OFC | mRNA stability | 4 | 0.370 | 2.1 |
PL | alternative polyA | 8 | 0.561 | 2.2 |
PL | alternative TSS | 7 | 0.596 | 2.0 |
PL | gene expression | 34 | 0.460 | 2.1 |
PL | isoform ratio | 2 | 0.090 | 1.9 |
PL | intron excision ratio | 6 | 0.167 | 2.0 |
PL | mRNA stability | 14 | 0.480 | 2.1 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.